Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
27 Nov 2025 Job Information Organisation/Company Academic Europe Research Field Biological sciences » Other Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Positions PhD
-
) Positions PhD Positions Country Germany Application Deadline 31 Jan 2026 - 23:59 (Europe/Berlin) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
3 Nov 2025 Job Information Organisation/Company Academic Europe Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country Germany
-
3 Nov 2025 Job Information Organisation/Company Academic Europe Research Field Biological sciences » Other Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Positions PhD
-
3 Nov 2025 Job Information Organisation/Company Academic Europe Research Field Biological sciences » Biology Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Positions PhD
-
) Positions PhD Positions Country Germany Application Deadline 6 Nov 2025 - 23:59 (Europe/Berlin) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme
-
programme Is the Job related to staff position within a Research Infrastructure? No Offer Description University of Würzburg and Helmholtz Institute for RNA-based Infection Research, GERMANY 1 PhD student & 1
-
, chromatin profiling, and advanced imaging. The successful candidate will have the opportunity to develop and lead their own independent research project and build a small research team by hiring PhD students
-
design, data analysis and interpretation of the results Organization of logistical aspects of the service schedule Your profile: PhD in life sciences, preferably cell biology, plant cell biology
-
. REQUIREMENTS: A PhD, MD, or equivalent degree in life sciences High academic qualifications (habilitation) or equivalent academic qualifications An internationally recognized track record of excellence in cancer